Zoetis | ZTS - Net Income




Zoetis reported $581M in Net Income for its fiscal quarter ending in December of 2024.

Net Income Change Date
AbbVie USD -22000000 1.58B Dec/2024
Align Technology USD 103.81M 12.15M Dec/2024
Bayer EUR -4183000000 4.15B Sep/2024
Bristol-Myers Squibb USD 72M 1.14B Dec/2024
Charles River Laboratories USD -203793000 272.47M Dec/2024
Dentsply International USD -494000000 490M Sep/2024
Eli Lilly USD 4.41B 3.44B Dec/2024
Henry Schein USD 99M 5M Sep/2024
Idexx Laboratories USD 216.15M 16.69M Dec/2024
Illumina USD 187M 518M Dec/2024
IQVIA Holdings USD 437M 152M Dec/2024
J&J USD 3.43B 737M Dec/2024
Laboratory Of America USD 143.4M 25.9M Dec/2024
Merck USD 3.74B 586M Dec/2024
Neogen USD -456280000 443.67M Nov/2024
Pacira USD -143466000 162.36M Sep/2024
Patterson Companies USD 26.77M 0 Oct/2024
Perrigo USD -21000000 87.4M Sep/2024
Pfizer USD 410M 4.06B Dec/2024
Quest Diagnostics USD 222M 4M Dec/2024
Sanofi EUR 2.82B 1.7B Sep/2024
Sanofi EUR 2.82B 1.7B Sep/2024
Zoetis USD 581M 101M Dec/2024